Grand Island, NENCT07680764Now EnrollingIRB Ready

Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Clinical Trial in Grand Island, NE

Access cutting-edge locally advanced non-small cell lung cancer (nsclc) treatment through this phase 2 clinical trial at a research site in Grand Island. Study-provided care at no cost to qualified participants.

Sponsored by Bristol-Myers Squibb

Quick Self-Assessment

See if you qualify for this Grand Island location

Preparing your pre-screening questions…

Expert Care in Grand Island

Access locally advanced non-small cell lung cancer (nsclc) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related locally advanced non-small cell lung cancer (nsclc) treatment provided free

Apply for This Grand Island Location

Check if you qualify for this locally advanced non-small cell lung cancer (nsclc) clinical trial in Grand Island, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Grand Island

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Grand Island site if eligible
  4. 4Begin participation

About This Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Study in Grand Island

The purpose of this study is to assess the safety, tolerability, and efficacy of Imzokitug in combination with Pumitamig and Platinum-Doublet Chemotherapy (PDCT) versus Pumitamig and PDCT as first-line treatment for participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Sponsor: Bristol-Myers Squibb

Who Can Participate

Inclusion Criteria

Participants must have histologically confirmed diagnosis of stage IV non-small cell lung cancer (NSCLC) (squamous or non-squamous) or recurrent unresectable disease per the American joint committee on cancer (AJCC) Staging System 9th edition.
Participants must have no prior systemic anti-cancer therapy given as primary therapy for advanced or metastatic disease.
Tumor tissue (fresh or archival) obtained within 5 months of enrollment (signing of informed consent) for each participant must be submitted by the site.
Participants must have an Eastern Cooperative Oncology Group Performance Status of 0 or 1.
Participants must have measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.

Exclusion Criteria

Participants must not have any documented actionable genomic alterations (AGAs) for which first line approved targeted therapies are indicated.
Participants must not have prior treatment with immuno-oncology therapies.
Participants must not have untreated central nervous system (CNS) metastases.
Other protocol-defined Inclusion/Exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Grand Island?

Yes, this clinical trial (NCT07680764) has an active research site in Grand Island, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Treatment Options in Grand Island, NE

If you're searching for locally advanced non-small cell lung cancer (nsclc) treatment options in Grand Island, NE, this clinical trial (NCT07680764) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Grand Island research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced locally advanced non-small cell lung cancer (nsclc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all locally advanced non-small cell lung cancer (nsclc) clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Grand Island, NE

See all lung cancer clinical trials recruiting in Grand Island — not just this study.

Browse Lung Cancer Trials in Grand Island →

Browse More Trials by Condition

Lung Cancer TrialsLeukemia TrialsSmall Cell Lung Cancer TrialsNon-Small Cell Lung Cancer TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsErectile Dysfunction TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in Grand Island?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Grand Island, NE